Catalyst Wire Dossier Catalyst Wire Dossier

Bupivacaine Liposome Injection

bupivacaine liposome injectable suspension · Jiangsu HengRui Medicine Co., Ltd.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Bupivacaine Liposome Injection, covering 2025-10-02 to 2026-03-12. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Bupivacaine Liposome Injection in the Treatment of Pain After Thoracoscopic Surgery [Phase 2]

See pricing